Transenterix (NYSE: TRXC) said Wednesday it's selling AutoLap’s assets to Great Belief International Limited for $47 million. The company also announced Great Belief International Limited is making an equity investment of $30 million In Transenterix’s common stock at $2.00 per share payable on or before Sept. 30.
Transenterix is a medical device company. AutoLap is an image-based scope positioning system used for traditional laparoscopic procedures.
"AutoLap has a track record of success with laparoscopic surgeons across a wide variety of procedures around the globe,” said TransEnterix CEO Todd Pope. “GBIL [Great Belief International[ has been a great partner for us in the past, and we believe they will be successful in bringing the benefits of the AutoLap product to the greatest number of laparoscopic surgeons worldwide."
Transenterix shares were trading up 35% at $1.72 at time of publication. The stock has a 52-week high of $6.98 and a 52-week low of $1.03.
Arthur J. Gallagher Acquires BluePeak Advisors
Altimmune To Acquire Spitfire Pharma For M, Add NASH Drug To Portfolio
Photo courtesy of Transenterix.
See more from Benzinga
- Ohr Pharmaceutical Merger With Neubase Therapeutics Approved By Shareholders
- Can-Fite BioPharma Appeals Lawsuit Against Venture Capital Firm
- Arthur J. Gallagher Acquires BluePeak Advisors
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.